الصفحة الرئيسية>>Signaling Pathways>> Chromatin/Epigenetics>> Epigenetic Reader Domain>>FHD-286

FHD-286

رقم الكتالوجGC64821

FHD-286 هو أحد مثبطات BRG1 / BRM ATPase لعلاج الاضطرابات المرتبطة بـ BAF مثل ابيضاض الدم النخاعي الحاد

Products are for research use only. Not for human use. We do not sell to patients.

FHD-286 التركيب الكيميائي

Cas No.: 2671128-05-3

الحجم السعر المخزون الكميّة
5 mg
405٫00
متوفر
10 mg
630٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

FHD-286 is a BRG1/BRM ATPase inhibitor for the treatment of BAF-related disorders such as acute myeloid leukemia.

[1]. Centore, Richard C. et al. Preparation of BRG1/BRM inhibitors for treating cancer. US20220079940 A1.

مراجعات

Review for FHD-286

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for FHD-286

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.